Evanston, IL, United States of America

Ernest F Levon

This inventor holds 3 USPTO granted patents. Top assignee: G.d. Searle & Company. Active years: 1976-1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ernest F Levon. Retrieved from https://idiyas.com/inventor/ernest-f-levon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1976-1980

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ernest F. Levon: Pharmaceutical and Radiopharmaceutical Patents.

Introduction

Ernest F. Levon is an inventor associated with Evanston, Illinois, and G. D. Searle & Company. His patent work includes pharmaceutical compounds and radiopharmaceutical imaging agents. His portfolio includes 3 patents.

Latest Patents

One of Levon’s patents describes sodium compounds labeled with radioactive technetium-99m, along with methods for preparing them. These complexes are presented as radiopharmaceutical imaging agents, particularly for imaging the gallbladder and liver.

Another patent concerns N-[2-(nitro-1-imidazolyl)ethyl] naphthalimides. The described compounds are intended for use as antibacterial and antiprotozoal agents. The patent also outlines preparation methods involving reactions with chloroethylimidazole or with tosylate or mesylate derivatives of the corresponding hydroxyethyl compound.

Career Highlights

Levon’s listed inventions reflect research into both diagnostic imaging and therapeutic compounds. His work at G. D. Searle & Company connects his patent activity with pharmaceutical research and development.

Collaborations

Patricia Frank and Stephen Kraychy are identified as Levon’s coworkers. Their names provide context for the professional network associated with his work.

Conclusion

Ernest F. Levon’s patents document contributions to radiopharmaceutical imaging and antimicrobial drug research, reflecting the range of pharmaceutical innovation represented in his portfolio.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…